Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Kestra Medical Technologies, Ltd. publishes a filing, an earnings call transcript or a press release.

Get KMTS alerts

About Vaseem Mahboob

Vaseem Mahboob is recorded as CFO at Kestra Medical Technologies, Ltd. (KMTS). The newest filing on record that lists Vaseem Mahboob as CFO at Kestra Medical Technologies, Ltd. (KMTS) is dated July 28, 2026. The proxy statement of Kestra Medical Technologies, Ltd. reports total compensation of $2,267,344 for Vaseem Mahboob in fiscal 2026, including a base salary of $470,000. Disclosed compensation is on record for 3 fiscal years. Vaseem Mahboob has spoken on 4 earnings calls and 3 other investor events across 1 company, most recently for Kestra Medical Technologies, Ltd. on November 11, 2026. Kestra Medical Technologies, Ltd. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Kestra Medical Technologies, Ltd. includes Brian Webster (CEO and Board Member), Traci S. Umberger (General Counsel and Board Member) and Conor Hanley (Board Member).

Vaseem Mahboob on recent calls

“Yeah, I think as we talked about on the call and the post calls, Rick, I think we have very clear line of sight to kind of our run rates, and we are a run rate business.”
CFO, Stifel Healthcare Conference 2026 ·
“So, to your point, we've made a lot of progress in the last year and a half. If you remember when we went public, we had 67% of our patients were in network. We're in the low 80s now, so really good progress.”
CFO, Wolfe Research Healthcare Conference 2026 ·
“We had a strong financial performance across the board in the fourth quarter. Total revenue was $28.6 million and an increase of 66% compared to the prior year period.”
CFO, Kestra Medical Technologies, Ltd. Q4 FY2026 Earnings Call ·
“So I think the financial model that we had put out there, Travis, was based on a rep starting doing about 40 fittings in the first six months as they ramp up.”
CFO, BofA Securities 2026 Healthcare Conference ·
“Total revenue was $24.6 million in the third quarter, an increase of 63 percent compared to the prior year period.”
CFO, Kestra Medical Technologies, Ltd. Q3 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Kestra Medical Technologies, Ltd.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 Kestra Medical Technologies, Ltd. (KMTS) $470,000 $2,267,344
2025 Kestra Medical Technologies, Ltd. (KMTS) $427,828 $2,323,082
2024 Kestra Medical Technologies, Ltd. (KMTS) $397,515 $530,176

Recent activity